Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor–CD74 signaling
- 3 December 2025
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (827) , eadr2277
Abstract
Aberrant proteostasis in alveolar type 2 epithelial cells (AEC2s) contributes to idiopathic pulmonary fibrosis (IPF), but the role of the ubiquitin-proteasome system (UPS) is unclear. Here, we show that UPS disruption in AEC2s amplifies profibrotic signaling to macrophages through macrophage migration inhibitory factor (MIF) family proteins in several models. Modeling UPS disruption with an AEC2-specific cullin 3 ( Cul3 ) deletion produced spontaneous fibrosis in a physiological aging mouse model and exacerbated fibrosis in the bleomycin-induced lung injury model. This was accompanied by expansion of transitional epithelial states and increased MIF and MIF-2 in lung tissue and bronchoalveolar lavage fluid (BALF) in the model. Global or conditional AEC2-specific deletions of Mif or Mif-2 attenuated fibrosis in the bleomycin-treated mouse model, as did conditional deletions of Cd74 , the cognate receptor for MIF and MIF-2, in C-X3-C motif chemokine receptor 1 ( Cx3cr1 )–expressing and platelet factor 4 ( Pf4 )–expressing cells. Pharmacological inhibition of MIF attenuated fibrosis in bleomycin-treated and transforming growth factor–β1 ( TGFB1 ) transgenic mouse models and in ex vivo human precision-cut lung slices treated with fibrotic cocktail. In study participants with IPF, BALF MIF was elevated compared with that in study participants without IPF. In participants with IPF, BALF MIF greater than 4000 picograms per milliliter was associated with increased mortality compared with participants with IPF with lower MIF. Together, these findings define a UPS-sensitive epithelial-macrophage signaling connection and identify MIF-CD74 cross-talk as a potential therapeutic target in fibrotic lung disease.Keywords
Funding Information
- National Institutes of Health (R01 HL155948)
- National Institutes of Health (NIH RO1AR078334)
- National Institutes of Health (R01HL141852)
- National Institutes of Health (U01HL145567)
- National Institutes of Health (R21HL161723)
- National Institutes of Health (P01HL11450)
- National Institutes of Health (1R01AG082433)
- National Institutes of Health (1RO1HL147860)
- National Institutes of Health (R01 HL109233)
- Greenfield Foundation
- Gabriel and Alma Elias Research Fund
- National Institutes of Health (HL152677)
- National Institutes of Health (HL125850)
- U.S. Department of War (DOD PR211314)
- G Harold and Leila Y. Mathers Foundation
- U.S. Department of War (1PR211819P1)
- Three Lakes Foundation
This publication has 75 references indexed in Scilit:
- Patient-specific iPSCs carrying an SFTPC mutation reveal the intrinsic alveolar epithelial dysfunction at the inception of interstitial lung diseaseCell Reports, 2021
- The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosisCellular Signalling, 2020
- Progressive Pulmonary Fibrosis Is Caused by Elevated Mechanical Tension on Alveolar Stem CellsCell, 2020
- The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLEInternational Immunopharmacology, 2019
- Comprehensive Integration of Single-Cell DataCell, 2019
- Repair and Regeneration of the Respiratory System: Complexity, Plasticity, and Mechanisms of Lung Stem Cell FunctionCell Stem Cell, 2014
- D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine familyCytokine, 2012
- Critical role of proteostasis-imbalance in pathogenesis of COPD and severe emphysemaJournal of Molecular Medicine, 2011
- Optimization of N-benzyl-benzoxazol-2-ones as receptor antagonists of macrophage migration inhibitory factor (MIF)Bioorganic & Medicinal Chemistry Letters, 2010
- Structural Insights into NEDD8 Activation of Cullin-RING Ligases: Conformational Control of ConjugationCell, 2008